Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PARCOPA

CARBIDOPA; LEVODOPA

Standard Dose
25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PARCOPA is listed in Drugs@FDA under application 076699 (ANDA).

Marketing status: Discontinued Active ingredient CARBIDOPA; LEVODOPA Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor UCB INC Submission history Latest submission status date: 2010-12-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview PARCOPA is listed in Drugs@FDA under application 076699 (ANDA). Marketing status: Discontinued Active ingredient CARBIDOPA; LEVODOPA Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor UCB INC Submission history Latest submission status date: 2010-12-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.